C07K 14/62
Insulins
C07K14/62 (Insulins) appears on 1,003 US grants and 1,251 published applications in this corpus.
Search patents in C07K- Granted patents
- 1,003
- Published applications
- 1,251
- Assignees
- 522
- Inventors
- 2,237
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 4 | 0 |
| 1978 | 5 | 0 |
| 1979 | 2 | 0 |
| 1980 | 7 | 0 |
| 1981 | 2 | 0 |
| 1982 | 10 | 0 |
| 1983 | 7 | 0 |
| 1984 | 12 | 0 |
| 1985 | 4 | 0 |
| 1986 | 14 | 0 |
| 1987 | 13 | 0 |
| 1988 | 9 | 0 |
| 1989 | 9 | 0 |
| 1990 | 7 | 0 |
| 1991 | 14 | 0 |
| 1992 | 10 | 0 |
| 1993 | 11 | 0 |
| 1994 | 10 | 0 |
| 1995 | 17 | 0 |
| 1996 | 16 | 0 |
| 1997 | 24 | 0 |
| 1998 | 22 | 0 |
| 1999 | 28 | 0 |
| 2000 | 18 | 0 |
| 2001 | 16 | 11 |
| 2002 | 17 | 30 |
| 2003 | 17 | 51 |
| 2004 | 18 | 29 |
| 2005 | 18 | 36 |
| 2006 | 17 | 46 |
| 2007 | 15 | 22 |
| 2008 | 17 | 41 |
| 2009 | 21 | 39 |
| 2010 | 16 | 33 |
| 2011 | 21 | 47 |
| 2012 | 14 | 44 |
| 2013 | 23 | 42 |
| 2014 | 37 | 87 |
| 2015 | 53 | 64 |
| 2016 | 53 | 62 |
| 2017 | 41 | 51 |
| 2018 | 38 | 58 |
| 2019 | 40 | 54 |
| 2020 | 45 | 73 |
| 2021 | 36 | 63 |
| 2022 | 37 | 61 |
| 2023 | 38 | 57 |
| 2024 | 22 | 53 |
| 2025 | 31 | 55 |
| 2026 | 20 | 42 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Selective MCL-1 binding peptides22 Sep 2026US 12,741,997 B2Massachusetts Institute of Technology
- Insulin-Fc fusion proteins and methods of use to treat cancer22 Sep 2026US 12,742,000 B2Akston Biosciences Corporation
- Polyphenolic insulin18 Aug 2026US 12,708,659 B2Kimball Westward LLC
- Conjugates for selective responsiveness to vicinal diols18 Aug 2026US 12,709,622 B2Protomer Technologies, Inc.
- Method for reducing misincorporation of non-canonical branched-chain amino acids11 Aug 2026US 12,703,876 B2Sanofi-Aventis Deutschland GmbH
- Fusion proteins of il-24 and immunostimulatory cytokines, nk cells expressing il-24 or fusion proteins, and methods of use thereof8 Oct 2026US 2026/0308218 A1Virginia Commonwealth University
- Ribosomal Remodeling in Diabetes1 Oct 2026US 2026/0295074 A1Joslin Diabetes Center, Inc.
- Insulin derivative and use thereof1 Oct 2026US 2026/0297155 A1The United Bio-Technology (Hengqin) Co., Ltd.
- Extended time action acylated insulin compounds24 Sep 2026US 2026/0285933 A1Eli Lilly and Company
- Low-cost cell-free insulin based on self amplifying rna10 Sep 2026US 2026/0265802 A1DEI Biopharma
Most cited
By later US patents
- Non-immunogenic polypeptides2,007US 4,179,337 A1979
- Engineered nucleic acids and methods of use thereof372US 8,822,663 B2Moderna Therapeutics, Inc. · 2014
- Expression using fused genes providing for protein product297US 4,751,180 AChiron Corporation · 1988
- Chimeric peptides for neuropeptide delivery through the blood-brain barrier238US 4,801,575 AThe Regents of the University of California · 1989
- Recombinant cloning vehicle microbial polypeptide expression228US 4,704,362 AGenentech, Inc. · 1987